- Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Bioorganic & medicinal chemistry letters (2010-11-09)
Yun W Alelyunas, James R Empfield, Dennis McCarthy, Russell C Spreen, Khanh Bui, Luciana Pelosi-Kilby, Cindy Shen
PMID21055935
ABSTRACT
We determined the experimental solubility of CNS marketed drugs. Of the 98 drugs measured, greater than 90% had solubility >10 μM in pH 7.4 buffer. Only seven drugs had solubility <10 μM. Using these data, we established a solubility criterion to support CNS discovery. The implication of poor solubility with potential safety concerns and undesirable side effects are discussed.
MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto
Supelco
Δ9-Tetrahydrocannabinol solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis